Ariceta, G., Collard, L., Abroug, S., Moochhala, S., Gould, E., Boussetta, A., . . . Schalk, G. (2023). ePHex: A phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Chicago Style CitationAriceta, G., et al. EPHex: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Evaluate Long-term Efficacy and Safety of Oxalobacter Formigenes in Patients With Primary Hyperoxaluria. 2023.
MLA CitationAriceta, G., et al. EPHex: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Evaluate Long-term Efficacy and Safety of Oxalobacter Formigenes in Patients With Primary Hyperoxaluria. 2023.
Warning: These citations may not always be 100% accurate.